Citation 183666

SALTZ,L: SIROTT,M: YOUNG,C: TONG,W: NIEDZWIECKI,D: YAO,TJ: TOA,Y: TROCHANOWSKI,B: WRIGHT,P: BARBOSA,K: TOOMASI,F: KELSEN,D:. (1993). PHASE I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR.. 85(18)

Citation Details

TitlePHASE I CLINICAL AND PHARMACOLOGY STUDY OF TOPOTECAN GIVEN DAILY FOR 5 CONSECUTIVE DAYS TO PATIENTS WITH ADVANCED SOLID TUMORS, WITH ATTEMPT AT DOSE INTENSIFICATION USING RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR.
AuthorsSALTZ,L: SIROTT,M: YOUNG,C: TONG,W: NIEDZWIECKI,D: YAO,TJ: TOA,Y: TROCHANOWSKI,B: WRIGHT,P: BARBOSA,K: TOOMASI,F: KELSEN,D:
Year1993
Volume85
Issue18

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TOPOTECAN*
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TOPOTECAN*
STRONG ACTIVITY
Show SPARQL Queries (1)